Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events

Smith, M.R., Coleman, R.E. orcid.org/0000-0002-4275-1043, Klotz, L. et al. (9 more authors) (2015) Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events. Annals of Oncology, 26 (2). pp. 368-374. ISSN 0923-7534

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: denosumab; zoledronic acid; symptomatic skeletal events; skeletal-related events; prostate cancer; phase III
Dates:
  • Published: February 2015
  • Published (online): 25 November 2014
  • Accepted: 2 October 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 04 May 2017 09:55
Last Modified: 04 May 2017 09:57
Published Version: https://doi.org/10.1093/annonc/mdu519
Status: Published
Publisher: Oxford University Press (OUP)
Refereed: Yes
Identification Number: https://doi.org/10.1093/annonc/mdu519
Related URLs:

Share / Export

Statistics